Exact Sciences website: (re: dna stool testing) Clinical Trial for average at risk patients

Blogger's Note: there are no dates on some of the website's pages

Clinical Trial

DeeP-C (Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer)

Exact Sciences is conducting a pivotal trial for the company’s multi-marker molecular diagnostic screening test for the early detection of colorectal cancer. The multi-center DeeP-C study will generate data to support Exact Sciences’ planned PMA submission to the U.S. Food and Drug Administration (FDA).  Exact Sciences is planning to have approximately 60 sites in the U.S. and Canada participate in the study. Those sites are expected to enroll more than 10,000 patients between the ages of 50 and 84 who are at average risk for colorectal cancer. For more information on the study please go to:
www.clinicaltrials.gov

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer (DeeP-C)

This study is currently recruiting participants.

Verified August 2011 by Exact Sciences Corporation

First Received on July 18, 2011.   Last Updated on March 30, 2012   History of Changes

(excluded from trial (high risk):

1. Subject has a family history of:
   • Familial adenomatous polyposis (also referred to as "FAP").
   • Hereditary non-polyposis colorectal cancer syndrome (also referred to as "HNPCC" or "Lynch Syndrome").

 

The Exact CRC screening test is an investigational device and is not available for sale in the United States.